Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) 3-Year Book Growth Rate : 71.50% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Wuhan Easy Diagnosis Biomedicine Co 3-Year Book Growth Rate?

Wuhan Easy Diagnosis Biomedicine Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥26.00.

During the past 12 months, Wuhan Easy Diagnosis Biomedicine Co's average Book Value per Share Growth Rate was -8.20% per year. During the past 3 years, the average Book Value per Share Growth Rate was 71.50% per year. During the past 5 years, the average Book Value per Share Growth Rate was 70.40% per year. During the past 10 years, the average Book Value per Share Growth Rate was 48.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Wuhan Easy Diagnosis Biomedicine Co was 111.60% per year. The lowest was -10.70% per year. And the median was 56.40% per year.

Competitive Comparison of Wuhan Easy Diagnosis Biomedicine Co's 3-Year Book Growth Rate

For the Medical Devices subindustry, Wuhan Easy Diagnosis Biomedicine Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuhan Easy Diagnosis Biomedicine Co's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wuhan Easy Diagnosis Biomedicine Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Wuhan Easy Diagnosis Biomedicine Co's 3-Year Book Growth Rate falls into.

Wuhan Easy Diagnosis Biomedicine Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Wuhan Easy Diagnosis Biomedicine Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Wuhan Easy Diagnosis Biomedicine Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Dongxin Road, 2 Floor, Building E, International Students Pioneer Park, Guandong Science and Technology Park, Donghu Development Zone, Hubei, Wuhan, CHN, 430075

Website

http://www.mdeasydiagnosis.com

Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.

Executives

Wang Rui	Directors, executives
Wang Jian Fei	Director

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Headlines

No Headlines